News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
712,386 Results
Type
Article (41799)
Company Profile (269)
Press Release (670317)
Multimedia
Podcasts (64)
Webinars (15)
Section
Business (206161)
Career Advice (2045)
Deals (35672)
Drug Delivery (100)
Drug Development (81722)
Employer Resources (176)
FDA (16437)
Job Trends (14995)
News (348606)
Policy (33107)
Tag
Academia (2614)
Accelerated approval (10)
Adcomms (23)
Allergies (99)
Alliances (50385)
ALS (109)
Alzheimer's disease (1455)
Antibody-drug conjugate (ADC) (155)
Approvals (16419)
Artificial intelligence (315)
Autoimmune disease (29)
Automation (18)
Bankruptcy (363)
Best Places to Work (11702)
BIOSECURE Act (21)
Biosimilars (126)
Biotechnology (190)
Bladder cancer (94)
Brain cancer (33)
Breast cancer (365)
Cancer (2879)
Cardiovascular disease (211)
Career advice (1712)
Career pathing (30)
CAR-T (185)
CDC (31)
Cell therapy (507)
Cervical cancer (22)
Clinical research (67214)
Collaboration (1031)
Company closure (3)
Compensation (680)
Complete response letters (23)
COVID-19 (2669)
CRISPR (58)
C-suite (327)
Cystic fibrosis (112)
Data (2982)
Decentralized trials (2)
Denatured (23)
Depression (59)
Diabetes (350)
Diagnostics (6471)
Digital health (24)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (138)
Drug pricing (126)
Drug shortages (28)
Duchenne muscular dystrophy (127)
Earnings (87735)
Editorial (42)
Employer branding (22)
Employer resources (151)
Events (114712)
Executive appointments (858)
FDA (18089)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (934)
Gene editing (132)
Generative AI (23)
Gene therapy (386)
GLP-1 (790)
Government (4609)
Grass and pollen (4)
Guidances (181)
Healthcare (18962)
Huntington's disease (31)
IgA nephropathy (39)
Immunology and inflammation (155)
Immuno-oncology (8)
Indications (40)
Infectious disease (2843)
Inflammatory bowel disease (151)
Inflation Reduction Act (10)
Influenza (64)
Intellectual property (119)
Interviews (320)
IPO (16662)
IRA (45)
Job creations (3683)
Job search strategy (1449)
Kidney cancer (13)
Labor market (52)
Layoffs (502)
Leadership (18)
Legal (7998)
Liver cancer (80)
Lung cancer (405)
Lymphoma (207)
Machine learning (11)
Management (59)
Manufacturing (391)
MASH (90)
Medical device (13556)
Medtech (13561)
Mergers & acquisitions (19723)
Metabolic disorders (852)
Multiple sclerosis (97)
NASH (16)
Neurodegenerative disease (118)
Neuropsychiatric disorders (31)
Neuroscience (2130)
NextGen: Class of 2025 (6578)
Non-profit (4525)
Now hiring (47)
Obesity (429)
Opinion (226)
Ovarian cancer (100)
Pain (104)
Pancreatic cancer (122)
Parkinson's disease (186)
Partnered (23)
Patents (298)
Patient recruitment (161)
Peanut (54)
People (58229)
Pharmaceutical (66)
Pharmacy benefit managers (21)
Phase I (20974)
Phase II (29584)
Phase III (22045)
Pipeline (1628)
Policy (206)
Postmarket research (2579)
Preclinical (8951)
Press Release (71)
Prostate cancer (139)
Psychedelics (36)
Radiopharmaceuticals (253)
Rare diseases (467)
Real estate (6030)
Recruiting (68)
Regulatory (22997)
Reports (51)
Research institute (2372)
Resumes & cover letters (353)
Rett syndrome (10)
RNA editing (8)
RSV (50)
Schizophrenia (88)
Series A (157)
Series B (108)
Service/supplier (11)
Sickle cell disease (62)
Special edition (18)
Spinal muscular atrophy (150)
Sponsored (33)
Startups (3653)
State (2)
Stomach cancer (14)
Supply chain (76)
Tariffs (59)
The Weekly (39)
Vaccines (805)
Venture capital (53)
Weight loss (257)
Women's health (45)
Worklife (16)
Date
Today (16)
Last 7 days (372)
Last 30 days (1898)
Last 365 days (31481)
2025 (16780)
2024 (35524)
2023 (40388)
2022 (51541)
2021 (56109)
2020 (54502)
2019 (46958)
2018 (35376)
2017 (32554)
2016 (31919)
2015 (38016)
2014 (31746)
2013 (26799)
2012 (28963)
2011 (29649)
2010 (27632)
Location
Africa (738)
Alabama (61)
Alaska (7)
Arizona (243)
Arkansas (13)
Asia (38973)
Australia (6330)
California (7447)
Canada (2353)
China (676)
Colorado (324)
Connecticut (317)
Delaware (193)
Europe (84107)
Florida (1118)
Georgia (247)
Hawaii (1)
Idaho (60)
Illinois (641)
India (26)
Indiana (363)
Iowa (17)
Japan (227)
Kansas (108)
Kentucky (29)
Louisiana (14)
Maine (64)
Maryland (1045)
Massachusetts (5556)
Michigan (245)
Minnesota (459)
Mississippi (3)
Missouri (90)
Montana (29)
Nebraska (25)
Nevada (80)
New Hampshire (67)
New Jersey (2081)
New Mexico (28)
New York (2096)
North Carolina (1086)
North Dakota (10)
Northern California (3267)
Ohio (240)
Oklahoma (16)
Oregon (35)
Pennsylvania (1615)
Puerto Rico (17)
Rhode Island (36)
South America (1120)
South Carolina (34)
South Dakota (1)
Southern California (2788)
Tennessee (125)
Texas (1117)
United States (27664)
Utah (221)
Virginia (183)
Washington D.C. (73)
Washington State (631)
West Virginia (4)
Wisconsin (65)
712,386 Results for "biological dynamics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Biological Dynamics Announces Expanding Adoption of ExoVerita™ Pro Under Early Access Program
Biological Dynamics Announces Expanding Adoption of ExoVerita™ Pro Under Early Access Program.
April 2, 2024
·
3 min read
Press Releases
Vivex Biologics, Inc. Executive Chair Nominated for Ernst & Young LLP Entrepreneur of the Year® 2025 Florida Award
May 16, 2025
·
3 min read
Press Releases
NurExone Biologic Inc. Announces First Quarter 2025 Financial Results and Provides Corporate Update
May 27, 2025
·
13 min read
Biotech Beach
Biological Dynamics Announces Early Access Program to Its ExoVerita™ Pro Platform
Biological Dynamics, Inc. announced the first opportunity for external users to access the company’s ExoVerita Pro, a cost-efficient, automated exosomal enrichment platform that delivers samples with best-in-class yields, purity, and reproducibility.
November 8, 2023
·
2 min read
Business
Biological Dynamics and The Pancreatic Cancer Early Detection Consortium (PRECEDE) Collaborate to Improve Surveillance of Early Pancreatic Cancer
Biological Dynamics, Inc. and the Pancreatic Cancer Early Detection (PRECEDE) Consortium have signed a multi-year agreement to partner on patient surveillance for early-stage pancreatic cancer using Biological Dynamics’ ExoVita Pancreas Assay, powered by the Verita platform.
September 6, 2023
·
4 min read
Press Releases
FUJIFILM Cellular Dynamics Appoints Delara Motlagh as Chief Operating Officer
April 30, 2025
·
4 min read
Press Releases
Biocon Biologics and Civica, Inc. Collaborate to Expand Insulin Aspart Access in the United States
March 7, 2025
·
6 min read
Press Releases
NurExone Biologic Inc. Announces Fourth Quarter and Full-Year 2024 Financial Results and Provides Corporate Update
April 10, 2025
·
15 min read
Press Releases
GenSight Biologics Reports Cash Position as of June 30, 2025
July 9, 2025
·
5 min read
Biotech Beach
Leading Academic Medical Centers Join Biological Dynamics’ ExoLuminate™ Study, Expanding Enrollment for Early Pancreatic Cancer Detection
Biological Dynamics, Inc., a leader in exosome-isolation technology for early disease detection, today announced that its ExoLuminate Study is expanding subject enrollment with the addition of four leading institutions in cancer treatment and research: the Dana-Farber Cancer Institute; Moores Cancer Center at UC San Diego Health; University of Florida Health; and MedStar Georgetown.
December 5, 2023
·
3 min read
1 of 71,239
Next
